Ishihara color vision testing was normal, and systemic workup revealed no symptoms or laboratory evidence, i.e., C-reactive protein, thrombocytes and sedimentation rate, suggestive of giant cell arteritis (GCA)
Tracking also helps distinguish between true hunger (a physiological signal that the medication is no longer suppressing appetite) and habitual eating patterns, emotional eating, or environmental triggers
The earlier SUSTAIN dose-finding studies for diabetes (Nauck et al., Diabetes Care, 2016) tested multiple dose levels including 0.05 mg, 0.1 mg, 0.2 mg, 0.3 mg, and 0.4 mg daily (note: daily, not weekly) of oral semaglutide and found dose-dependent reductions in HbA1c and body weight at every dose tested
Madamanchi A -Adrenergic receptor signaling in cardiac function and heart failure
The half-life and microdosing calculators are specifically designed for GLP-1 medications with long half-lives